Parkinson’s well-studied involvement of key pathways such as mitochondrial dysfunction, alpha-synuclein aggregation, and neuroinflammation, which are also implicated in other neurodegenerative diseases, makes it a suitable reference for a cross-disease WGCNA approach [46,47]. The gene discussed is SNCA; the disease is neurodegenerative disease.